AMCP supports the concept of collaborative drug therapy management (CDTM), a formal partnership between a pharmacist and a prescriber that allows the pharmacist to manage a patient`s drug therapy. CdTM, also known as collaborative practice, allows pharmacists to use their unique skills and skills to complement other types of care provided by cooperating professionals to optimize patient outcomes. As health care in the United States evolves through models such as responsible care organizations and medical institutions, it is in the best interests of patient care that pharmacists be recognized as an integral part of the health team. Collaborative Drug Therapy Management (CDTM) is practiced in the United States and is officially recognized in 25 states and recognized by the federal government (armed forces and veterans affairs). THE CDTM asks the pharmacist to work with the doctor to ensure optimal therapeutic management. In the CDTM agreement, the doctor delegates the power of management to the pharmacist as part of a formal agreement. The collaborative management authority may include laboratory testing, patient evaluation, initiation and modification of drug therapy, patient monitoring and drug delivery. This article describes THE regulatory and practical status of CDTM as well as training, reimbursement and liability issues. The collaborative drug therapy management (CDTM), also known as coordinated management of drug therapy, involves the development of a collaborative practice agreement (CPA) between one or more health care providers and pharmacists. What is CDTM and why is it important to pharmacists? The CDTM requires a professional partnership between physicians and pharmacists with the explicit aim of managing drug treatments and disease conditions. Activities may include initiation, modification and monitoring of drug therapy; Ordering and conducting laboratory tests Assessing patients` reactions to treatment; Educating and consulting patients and the administration of medicines. For example, in 2006, the CDTM program, a pharmaceutical assistant in Missouri, resulted in a 12% decrease in hospital stays, a 25% reduction in the number of emergency visits and a 25% reduction in the number of visits to beneficiaries in 2006.